4//SEC Filing
Apelian David 4
Accession 0001209191-17-056344
CIK 0001305253other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 6:51 PM ET
Size
8.5 KB
Accession
0001209191-17-056344
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-09-28+25,000→ 25,000 totalExercise: $10.75Exp: 2027-09-28→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from June 14, 2017 subject to Reporting Person's continuous service status as of each such date.
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001546842
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 6:51 PM ET
- Size
- 8.5 KB